Polylactic Acid Salt Nanoparticle Kit for Stable On-Demand Drug Encapsulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing nanoparticle compositions for drug delivery, particularly those using cationic lipids or polycationic polymers, are unstable and require complex production processes, making them vulnerable to storage and transportation environments, and are difficult for end users to prepare effectively.
Innovation Solution
A kit comprising separate chambers with amphiphilic block copolymer, cationic compound, and polylactic acid salt, along with an effective ingredient such as nucleic acid or virus, allows for simple mixing to form stable nanoparticles suitable for drug delivery, isolating components to maintain stability and ease of use.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If nanoparticles are formed using cationic lipid or polycationic polymer complexes, then intracellular delivery is improved, but stability under storage and transportation conditions deteriorates
Solution Approach 1:
The kit divides the nanoparticle formation system into separate components stored in different chambers: cationic compounds (lipids or polymers) in the first chamber, and anionic drugs (nucleic acids) in the second chamber. This segmentation allows each component to be stored stably in isolation, preventing premature complex formation, while enabling nanoparticle assembly only when needed by mixing the chambers together.
2Ease of operation
If nanoparticles are prepared in advance for drug delivery, then convenience for end users is improved, but stability under storage and transportation conditions deteriorates
Solution Approach 1:
The kit performs preliminary preparation by pre-formulating and storing stable stock solutions of cationic compounds and anionic drugs in separate chambers. The components are prepared in advance with optimized concentrations and formulations for stability, but the actual nanoparticle formation is deferred until mixing at the point of use, combining the benefits of pre-preparation with post-delayed assembly.
3Stability of the object's composition
If a complicated production process is used to secure nanoparticle stability, then nanoparticle stability is improved, but manufacturing complexity increases
Solution Approach 1:
The system enables self-service nanoparticle formation where the cationic and anionic components automatically self-assemble into nanoparticles through electrostatic attraction when mixed. This spontaneous self-assembly process eliminates the need for complex external intervention, specialized equipment, or multi-step manufacturing procedures, achieving stable nanoparticle formation through simple mixing of pre-formulated components.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The kit enables the formation of stable nanoparticles with effective drug delivery capabilities, unaffected by storage or transportation conditions, and can be easily prepared by end users, ensuring efficient intracellular delivery of drugs.
Implementation Method 1
a complex of cationic lipid and nucleic acid (lipoplex) and a complex of polycationic polymer and nucleic acid (polyplex). Such a cationic lipid or polycationic polymer stabilizes anionic drug by forming a complex through electrostatic interaction with the anionic drug and increases intracellular delivery
Implementation Method 2
amphiphilic block copolymer, cationic compound, salt of polylactic acid
Data Source
AI summary
The present invention relates to a kit for preparing a nanoparticle composition for drug delivery and, more specifically, to a kit for preparing a nanoparticle composition for drug delivery, which is designed to easily form a nanoparticle in which a drug is encapsulated by simply mixing an amphiphilic block copolymer, a cationic compound, a polylactic acid salt, and the drug that are the components of the kit.